Korupolu Radha, Stampas Argyrios, Gibbons Carlee, Hernandez Jimenez Isaac, Skelton Felicia, Verduzco-Gutierrez Monica
Department of Physical Medicine and Rehabilitation, McGovern Medical School, The University of Texas Health Science Center, Houston, TX, USA.
The Institute of Rehabilitation & Research (TIRR) Memorial Hermann, Houston, TX, USA.
Spinal Cord Ser Cases. 2020 May 11;6(1):35. doi: 10.1038/s41394-020-0284-7.
An outbreak of a novel coronavirus disease (COVID-19) that emerged in the Chinese city of Wuhan has rapidly become a global public health pandemic. As of March 2020, the Centers for Disease Control and Prevention (CDC) has described priority levels for testing patients with suspected COVID-19 and information on when to seek medical attention. However, there is a paucity of further guidance for people with spinal cord injury (SCI) who may not present with typical symptoms of COVID-19 due to altered physiology. This may pose challenges with surveillance, risk stratification, and initial management of this vulnerable population. In this point-counterpoint discussion, we outline important differences in presentation along with COVID-19 cases co-morbid with SCI.
在中国武汉市出现的新型冠状病毒疾病（COVID-19）疫情已迅速演变成一场全球公共卫生大流行。截至2020年3月，美国疾病控制与预防中心（CDC）已描述了对疑似COVID-19患者进行检测的优先级别以及何时寻求医疗护理的信息。然而，对于因生理改变可能不会出现COVID-19典型症状的脊髓损伤（SCI）患者，缺乏进一步的指导。这可能给对这一弱势群体的监测、风险分层和初始管理带来挑战。在这场针锋相对的讨论中，我们概述了COVID-19合并SCI病例在临床表现方面的重要差异。
